Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Clinical Cardiology|April 20, 2016
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United StatesShravanthi R Gandra, Guillermo Villa, Gregg C Fonarow, et al.BMC Nephrology|January 26, 2012
Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational studyKathleen M Fox, Jerry Yee, Ze Cong, et al.The American Journal of Cardiology|January 9, 2016
A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary EventRuben G W Quek, Kathleen M Fox, Li Wang, et al.Expert Review of Pharmacoeconomics & Outcomes Research|November 11, 2016
Productivity losses associated with cardiovascular disease: a systematic reviewAdam L Gordois, Peter P Toth, Ruben Gw Quek, et al.Journal of Managed Care Pharmacy : JMCP|September 20, 2006
Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular diseaseShravanthi R Gandra, Lesa W Lawrence, Bhash M Parasuraman, et al.Current Medical Research and Opinion|November 7, 2009
Successes and challenges of insulin therapy for type 2 diabetes in a managed-care settingGregory A Nichols, Shravanthi R Gandra, Chiun-Fang Chiou, et al.Clinical Cardiology|June 24, 2015
Burden of First and Recurrent Cardiovascular Events Among Patients With HyperlipidemiaRajeshwari S Punekar, Kathleen M Fox, Akshara Richhariya, et al.Current Medical Research and Opinion|January 12, 2017
A systematic review to assess adherence and persistence with statinsSohan Deshpande, Ruben G W Quek, Carol A Forbes, et al.Current Medical Research and Opinion|March 10, 2017
Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort studyRajeshwari S Punekar, Kathleen M Fox, Carly J Paoli, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational studyStephen Seliger, Kathleen M Fox, Shravanthi R Gandra, et al.Pageof 6